Refine
Has Fulltext
- yes (8)
Is part of the Bibliography
- yes (8)
Document Type
- Journal article (7)
- Doctoral Thesis (1)
Language
- English (8)
Keywords
- AIDS (1)
- Alpelisib (1)
- Bubble Universes (1)
- German Hepatitis C-Registry (1)
- HEALPix (1)
- HSC (1)
- Inflationäres Weltall (1)
- Inhomogeneous Cosmological Models (1)
- Israel Junction Conditions (1)
- Kosmische Hintergrundstrahlung (1)
Institute
Genome-wide association studies (GWAS) have identified more than 170 breast cancer susceptibility loci. Here we hypothesize that some risk-associated variants might act in non-breast tissues, specifically adipose tissue and immune cells from blood and spleen. Using expression quantitative trait loci (eQTL) reported in these tissues, we identify 26 previously unreported, likely target genes of overall breast cancer risk variants, and 17 for estrogen receptor (ER)-negative breast cancer, several with a known immune function. We determine the directional effect of gene expression on disease risk measured based on single and multiple eQTL. In addition, using a gene-based test of association that considers eQTL from multiple tissues, we identify seven (and four) regions with variants associated with overall (and ER-negative) breast cancer risk, which were not reported in previous GWAS. Further investigation of the function of the implicated genes in breast and immune cells may provide insights into the etiology of breast cancer.
At the present day the idea of cosmological inflation constitutes an important extension of Big Bang theory. Since its appearance in the early 1980’s many physical mechanisms have been worked out that put the inflationary expansion of space that proceeds the Hot Big Bang on a sound theoretical basis. Among the achievements of the theory of inflation are the explanaition of the almost Euclidean geometry of ‘visible’space, the homogeneity of the cosmic background radiation but, in particular, also the tiny inhomogeneity of a relative amplitude of 10−5. In many models of inflation the inflationary phase ends only locally. Hence, there exists the possibility that the inflationary process still goes on in regions beyond our visual horizon. This property is commonly termed ‘eternal inflation’. In the framework of a cosmological scalar fields, eternal inflation can manifest itself in a variety of ways. On the one hand fluctuations of the field, if sufficiently large, can work against the classical trajectory and therefore counteract the end of inflation. In regions where this is the case the accelerated expansion of space continues at a higher rate. In parts of this region the process may replicate itself again and in this way may continue throughout all of time. Space and field are said to reproduce themselves. On the other hand, a mechanism that can occur in addition or independent of the latter, is so called vacuum tunneling. If the potential of the scalar field has several local minima, a semi-classical calculation suggests that within a spherical region, a bubble, the field can tunnel to another state. The respective tunneling rates depend on the potential difference and the shape of the potential between the states. Generally, the tunneling rate is exponentially suppressed, which means that the inflation lasts for a long time before tunneling takes place. The ongoing inflationary process effectively reduces local curvature, anistotropy and inhomogeneity, so that this property is known as the ‘cosmic no-hair conjecture’. For this reason cosmological considerations of the evolution of bubbles thus far almost entirely involved vacuum (de Sitter) backgrounds. However, new insights in the framework of string theory suggest high tunneling rates which allow for the possibility of bubble nucleation in non-vacuum dominated backgrounds. In this case the evolution of the bubble depends on the properties of the background spacetime. A deeper introduction in chapter 4 is followed by the presentation of the Lemaître-Tolman spacetime in chapter 5 which constitutes the background spacetime in the study of the effect of matter and inhomogeneity on the evolution of vacuum bubbles. In chapter 6 we explicitly describe the application of the ‘thin-shell’ formalism and the resulting system of equations. This is succeeded in chapter 7 by the detailed analysis of bubble evolution in various limits of the Lemaître-Tolman spacetime and a Robertson-Walker spacetime with a rapid phase transition. The central observations are that the presence of dust, at a fixed surface energy density, goes along with a smaller nucleation volume and possibly leads to a a collapse of the bubble. In an expanding background, the radially inhomogeneous dust profile is efficiently diluted so that there is essentially no effect on the evolution of the domain wall. This changes in a radially inhomogeneous curvature profile, positive curvature decelerates the expansion of the bubble. Moreover, we point out that the adopted approach does not allow for a treatment of a, physically expected, matter transfer so that the results are to be understood as preliminary under this caveat. In the second part of this thesis we consider potential observable consequences of bubble collisions in the cosmic microwave background radiation. The topological nature of the signal suggests the use of statistics that are well suited to quantify the morphological properties of the temperature fluctuations. In chapter 10 we present Minkowski Functionals (MFs) that exactly provide such statistics. The presented error analysis allows for a higher precision of numerical MFs in comparison to earlier methods. In chapter 12 we present the application of our algorithm to a Gaussian and a collision map. We motivate the expected MFs and extract their numerical counterparts. We find that our least-squares fitting procedure accurately reproduces an underlying signal only when a large number of realizations of maps are averaged over, while for a single WMAP and PLANCK resolution map, only when a highly prominent disk, with |δT| = 2√σG and ϑd = 40◦, we are able to recover the result. This is unfortunate, as it means that MF are intrinsically too noisy to be able to distinguish cold and hot spots in the CMB for small sizes.
The direct estimation of heritability from genome-wide common variant data as implemented in the program Genome-wide Complex Trait Analysis (GCTA) has provided a means to quantify heritability attributable to all interrogated variants. We have quantified the variance in liability to disease explained by all SNPs for two phenotypically-related neurobehavioral disorders, obsessive-compulsive disorder (OCD) and Tourette Syndrome (TS), using GCTA. Our analysis yielded a heritability point estimate of 0.58 (se = 0.09, p = 5.64e-12) for TS, and 0.37 (se = 0.07, p = 1.5e-07) for OCD. In addition, we conducted multiple genomic partitioning analyses to identify genomic elements that concentrate this heritability. We examined genomic architectures of TS and OCD by chromosome, MAF bin, and functional annotations. In addition, we assessed heritability for early onset and adult onset OCD. Among other notable results, we found that SNPs with a minor allele frequency of less than 5% accounted for 21% of the TS heritability and 0% of the OCD heritability. Additionally, we identified a significant contribution to TS and OCD heritability by variants significantly associated with gene expression in two regions of the brain (parietal cortex and cerebellum) for which we had available expression quantitative trait loci (eQTLs). Finally we analyzed the genetic correlation between TS and OCD, revealing a genetic correlation of 0.41 (se = 0.15, p = 0.002). These results are very close to previous heritability estimates for TS and OCD based on twin and family studies, suggesting that very little, if any, heritability is truly missing (i.e., unassayed) from TS and OCD GWAS studies of common variation. The results also indicate that there is some genetic overlap between these two phenotypically-related neuropsychiatric disorders, but suggest that the two disorders have distinct genetic architectures.
The Serotonergic Central Nervous System of the Drosophila Larva: Anatomy and Behavioral Function
(2012)
The Drosophila larva has turned into a particularly simple model system for studying the neuronal basis of innate behaviors and higher brain functions. Neuronal networks involved in olfaction, gustation, vision and learning and memory have been described during the last decade, often up to the single-cell level. Thus, most of these sensory networks are substantially defined, from the sensory level up to third-order neurons. This is especially true for the olfactory system of the larva. Given the wealth of genetic tools in Drosophila it is now possible to address the question how modulatory systems interfere with sensory systems and affect learning and memory. Here we focus on the serotonergic system that was shown to be involved in mammalian and insect sensory perception as well as learning and memory. Larval studies suggested that the serotonergic system is involved in the modulation of olfaction, feeding, vision and heart rate regulation. In a dual anatomical and behavioral approach we describe the basic anatomy of the larval serotonergic system, down to the single-cell level. In parallel, by expressing apoptosis-inducing genes during embryonic and larval development, we ablate most of the serotonergic neurons within the larval central nervous system. When testing these animals for naive odor, sugar, salt and light perception, no profound phenotype was detectable; even appetitive and aversive learning was normal. Our results provide the first comprehensive description of the neuronal network of the larval serotonergic system. Moreover, they suggest that serotonin per se is not necessary for any of the behaviors tested. However, our data do not exclude that this system may modulate or fine-tune a wide set of behaviors, similar to its reported function in other insect species or in mammals. Based on our observations and the availability of a wide variety of genetic tools, this issue can now be addressed.
Human cysticercosis caused by Taenia crassiceps tapeworm larvae involves the muscles and subcutis mostly in immunocompromised patients and the eye in immunocompetent persons. We report a successfully treated cerebellar infection in an immunocompetent woman. We developed serologic tests, and the parasite was identified by histologic examination and 12s rDNA PCR and sequencing.
Bile salts accumulating during cholestatic liver disease are believed to promote liver fibrosis. We have recently shown that chenodeoxycholate (CDC) induces expansion of hepatic stellate cells (HSCs) in vivo, thereby promoting liver fibrosis. Mechanisms underlying bile salt-induced fibrogenesis remain elusive. We aimed to characterize the effects of different bile salts on HSC biology and investigated underlying signaling pathways. Murine HSCs (mHSCs) were stimulated with hydrophilic and hydrophobic bile salts. Proliferation, cell mass, collagen deposition, and activation of signaling pathways were determined. Activation of the human HSC cell line LX 2 was assessed by quantification of α-smooth muscle actin (αSMA) expression. Phosphatidyl-inositol-3-kinase (PI3K)-dependent signaling was inhibited both pharmacologically and by siRNA. CDC, the most abundant bile salt accumulating in human cholestasis, but no other bile salt tested, induced Protein kinase B (PKB) phosphorylation and promoted HSC proliferation and subsequent collagen deposition. Pharmacological inhibition of the upstream target PI3K-inhibited activation of PKB and pro-fibrogenic proliferation of HSCs. The PI3K p110α-specific inhibitor Alpelisib and siRNA-mediated knockdown of p110α ameliorated pro-fibrogenic activation of mHSC and LX 2 cells, respectively. In summary, pro-fibrogenic signaling in mHSCs is selectively induced by CDC. PI3K p110α may be a potential therapeutic target for the inhibition of bile salt-induced fibrogenesis in cholestasis.
Fanconi anemia (FA) is a genetically heterogeneous disorder with 22 disease-causing genes reported to date. In some FA genes, monoallelic mutations have been found to be associated with breast cancer risk, while the risk associations of others remain unknown. The gene for FA type C, FANCC, has been proposed as a breast cancer susceptibility gene based on epidemiological and sequencing studies. We used the Oncoarray project to genotype two truncating FANCC variants (p.R185X and p.R548X) in 64,760 breast cancer cases and 49,793 controls of European descent. FANCC mutations were observed in 25 cases (14 with p.R185X, 11 with p.R548X) and 26 controls (18 with p.R185X, 8 with p.R548X). There was no evidence of an association with the risk of breast cancer, neither overall (odds ratio 0.77, 95%CI 0.44–1.33, p = 0.4) nor by histology, hormone receptor status, age or family history. We conclude that the breast cancer risk association of these two FANCC variants, if any, is much smaller than for BRCA1, BRCA2 or PALB2 mutations. If this applies to all truncating variants in FANCC it would suggest there are differences between FA genes in their roles on breast cancer risk and demonstrates the merit of large consortia for clarifying risk associations of rare variants.
Using data from the German Hepatitis C-Registry (Deutsche Hepatitis C-Register, DHC-R), we report the real-world safety and effectiveness of glecaprevir/pibrentasvir (GLE/PIB) treatment and its impact on patient-reported outcomes (PROs) in underserved populations who are not typically included in clinical trials, yet who will be crucial for achieving hepatitis C virus (HCV) elimination. The DHC-R is an ongoing, non-interventional, multicenter, prospective, observational cohort study on patients treated for chronic HCV infection in Germany. The data cutoff was 17 January 2021. The primary effectiveness endpoint was sustained virologic response at post-treatment Week 12 (SVR12). Safety outcomes were assessed in all patients receiving GLE/PIB. PROs were assessed using the SF-36 survey. Of 2354 patients, 1964 had valid SVR12 data (intention-to-treat analysis). Of these, 1905 (97.0%) achieved SVR12 with rates similar across the comorbidities analyzed, except for people who actively use drugs (PWUD (active)) (86.4%). Excluding those who discontinued treatment and did not achieve SVR12, or were reinfected with HCV, the rate was 99.3%, with similar results regardless of comorbidity. PWUD (active) and those with psychiatric disorders had the most meaningful improvements in PROs. Adverse events (AEs) occurred in 631/2354 patients (26.8%), and serious AEs in 44 patients (1.9%). GLE/PIB was highly effective and well tolerated in this real-world study of patient groups key to HCV elimination.